Thomas Ernst
Impact in
- Hematology top 0.2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 113
- Chronic Myeloid Leukemia Treatments 79
- Acute Myeloid Leukemia Research 23
- Multiple Myeloma Research and Treatments 5
- Genetics 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Co-authors
- Andreas Hochhaus (101 shared papers)Nicholas C.P. Cross (29 shared papers)Andreas Reiter (14 shared papers)Andrew Chase (12 shared papers)J Score (9 shared papers)Claire Hidalgo-Curtis (10 shared papers)Katerina Zoi (9 shared papers)Amy V. Jones (7 shared papers)
- Journals
- Leukemia (33 papers)Blood (32 papers)Journal of Cancer Research and Clinical Oncology (14 papers)Annals of Hematology (9 papers)Haematologica (7 papers)
- Partner nations
- GermanyUnited KingdomItaly
In The Last Decade
Thomas Ernst
167 papers receiving 7.2k citations
Thomas Ernst's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 3.1k
- Genetics 800
- Pathology and Forensic Medicine 511
- Immunology 557
- Cancer Research 318
Countries citing papers authored by Thomas Ernst
This map shows the geographic impact of Thomas Ernst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ernst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ernst more than expected).
Fields of papers citing papers by Thomas Ernst
This network shows the impact of papers produced by Thomas Ernst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ernst. The network helps show where Thomas Ernst may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Ernst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 178 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Hit paper breakdown → | 2010 | 944 |
| 2 | Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial Hit paper breakdown → | 2018 | 561 |
| 3 | BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet Hit paper breakdown → | 2011 | 448 |
| 4 | 2009 | 316 | |
| 5 | 2020 | 264 | |
| 6 | 2002 | 228 | |
| 7 | 2011 | 219 | |
| 8 | 2013 | 219 | |
| 9 | 2017 | 194 | |
| 10 | 2019 | 190 | |
| 11 | 2009 | 179 | |
| 12 | 2008 | 171 | |
| 13 | 2011 | 140 | |
| 14 | 2020 | 124 | |
| 15 | 2013 | 119 | |
| 16 | 2014 | 116 | |
| 17 | 2019 | 110 | |
| 18 | 2018 | 108 | |
| 19 | 2016 | 98 | |
| 20 | 2008 | 96 |
About Thomas Ernst
Thomas Ernst is a scholar working on Hematology, Genetics, Otorhinolaryngology, Oncology and Cancer Research, having authored 178 papers that have together received 7.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (79 papers), Acute Myeloid Leukemia Research (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Head and Neck Cancer Studies (9 papers), Economic and Financial Impacts of Cancer (5 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer Genomics and Diagnostics (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Hematology (3.1k citations), Genetics (800 citations), Pathology and Forensic Medicine (511 citations), Immunology (557 citations) and Cancer Research (318 citations). Thomas Ernst has collaborated with scholars based in Germany, United Kingdom and Italy. Frequent co-authors include Andreas Hochhaus, Nicholas C.P. Cross, Andreas Reiter, Andrew Chase, J Score, Claire Hidalgo-Curtis, Katerina Zoi, Amy V. Jones, Francis Grand and Philipp Erben. Their work appears in journals such as Leukemia, Blood, Journal of Cancer Research and Clinical Oncology, Annals of Hematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.